Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link What is cagrilintide (glucagon like peptide 1 receptor agonist) used for in the management of type 2 diabetes and obesity? Semaglutide vs Tirzepatide, which is better for you? Cagrilintide medication for weight loss and appetite control Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine